Tag archive


Healthcare has a $20B “Super” Problem: Precision Medicine is Here to Cut Costs and Save Lives

in Pharmaceutical Articles
Precision Medicine is Here to Cut Costs and Save Lives

In recent years, biotech, pharmaceutical and healthcare executives have been dealing with a global crisis created by the prevalence of multi-drug resistant organisms (MDROs), or as they have come to be referred to more commonly, superbugs. The Centers for Disease Control and Prevention (CDC) estimates that antibiotic-resistant infections are responsible for two million illnesses and 23,000 deaths annually in the U.S. alone. These infections are not only widespread, they can be costly and challenging as many healthcare facilities lack access…

Keep Reading

ADC Bio Developing Downstream Bioconjugation Process

in Pharmaceutical News
ADC Biotechnology

New manufacturing paradigm will save 25% of total costs and Specialist Process Innovation Group created to validate approach Wales: ADC Biotechnology (ADC Bio) announces that it is developing a revolutionary, ‘downstream bioconjugation’ method that will present a new paradigm in Antibody Drug Conjugate (ADC) development and manufacturing. In contrast to the existing approaches – which undertake bioconjugation after both the mAb and cytotoxic have been manufactured – this new approach moves the conjugation step into the later stages of the downstream processing…

Keep Reading

Go to Top